Search research articles
Contact Us
Filters
Showing results (161-170 of 224) with videos related to
Page
of 23
Sort By:
Dermatology and Therapy
|
August 24, 2021
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older
Eric L Simpson, Amy S Paller, Elaine C Siegfried, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics
|
February 14, 2002
Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction
R Tazi-Ahnini, A Cox, A J G McDonagh, et al.
American Journal of Clinical Dermatology
|
May 22, 2023
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
Eric L Simpson, Jonathan I Silverberg, Jacob P Thyssen, et al.
Plos One
|
March 26, 2015
Stability of the octameric structure affects plasminogen-binding capacity of streptococcal enolase
Amanda J Cork, Daniel J Ericsson, Ruby H P Law, et al.
Mbio
|
May 2, 2019
An Experimental Group A <i>Streptococcus</i> Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model
Tania Rivera-Hernandez, Diane G Carnathan, Scott Jones, et al.
Journal of the American Academy of Dermatology
|
June 1, 1996
Cyclosporine in severe childhood atopic dermatitis: a multicenter study
J Berth-Jones, A Y Finlay, I Zaki, et al.
JAMA Dermatology
|
February 1, 2023
Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials
Amy S Paller, Jonathan I Silverberg, Michael J Cork, et al.
American Journal of Clinical Dermatology
|
March 28, 2026
Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis
Amy S Paller, Eric L Simpson, Elaine C Siegfried, et al.
The British Journal of Dermatology
|
December 2, 2017
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)
M de Bruin-Weller, D Thaçi, C H Smith, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 2, 2021
Randomized controlled pilot trial with ion-exchange water softeners to prevent eczema (SOFTER trial)
Z K Jabbar-Lopez, B Ezzamouri, A Briley, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 224) with videos related to
Sort By:
Page
of 23
Dermatology and Therapy
|
August 24, 2021
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older
Eric L Simpson, Amy S Paller, Elaine C Siegfried, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics
|
February 14, 2002
Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction
R Tazi-Ahnini, A Cox, A J G McDonagh, et al.
American Journal of Clinical Dermatology
|
May 22, 2023
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
Eric L Simpson, Jonathan I Silverberg, Jacob P Thyssen, et al.
Plos One
|
March 26, 2015
Stability of the octameric structure affects plasminogen-binding capacity of streptococcal enolase
Amanda J Cork, Daniel J Ericsson, Ruby H P Law, et al.
Mbio
|
May 2, 2019
An Experimental Group A <i>Streptococcus</i> Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model
Tania Rivera-Hernandez, Diane G Carnathan, Scott Jones, et al.
Journal of the American Academy of Dermatology
|
June 1, 1996
Cyclosporine in severe childhood atopic dermatitis: a multicenter study
J Berth-Jones, A Y Finlay, I Zaki, et al.
JAMA Dermatology
|
February 1, 2023
Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials
Amy S Paller, Jonathan I Silverberg, Michael J Cork, et al.
American Journal of Clinical Dermatology
|
March 28, 2026
Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis
Amy S Paller, Eric L Simpson, Elaine C Siegfried, et al.
The British Journal of Dermatology
|
December 2, 2017
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)
M de Bruin-Weller, D Thaçi, C H Smith, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 2, 2021
Randomized controlled pilot trial with ion-exchange water softeners to prevent eczema (SOFTER trial)
Z K Jabbar-Lopez, B Ezzamouri, A Briley, et al.
Page
of 23